ANALISE HUGHES: Open Payments
NPI 1083068167 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 98 payments from 16 companies in 2025. Trend: 2023 $657 · 2024 $858 · 2025 $1,849
Food & beverage: $1,849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $427 |
| Galderma Laboratories, L.P. | 20 | $333 |
| GENZYME CORPORATION | 16 | $186 |
| Janssen Biotech, Inc. | 8 | $178 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $168 |
| UCB, Inc. | 5 | $114 |
| Amgen Inc. | 5 | $96 |
| Incyte Corporation | 4 | $92 |
| LEO Pharma Inc. | 3 | $78 |
| Biofrontera Inc. | 2 | $55 |
Products named: RINVOQ, NEMLUVIO, DUPIXENT, TREMFYA, ILUMYA, Bimzelx, SKYRIZI, OTEZLA.
Industry payments across VA — which companies pay providers there.
